期刊文献+

不同剂量奥氮平治疗精神分裂症的疗效及对患者糖、脂代谢的影响 被引量:16

Curative effect and influence on glucose and lipid metabolism of olanzapine with different doses in patients with schizophrenia
下载PDF
导出
摘要 目的:探讨不同剂量奥氮平治疗精神分裂症的疗效及对患者糖、脂代谢的影响。方法:96例精神分裂症患者随机分为奥氮平低剂量组(50例,<10mg/d)和高剂量组(46例,>10mg/d);分别于治疗前、治疗2、4、8周末采用阳性与阴性症状量表(PANSS)进行评分,并检测体质量指数(BMI)、血糖及血脂;8周末评价疗效。结果:低剂量组和高剂量组起效时间和疗效比较差异无统计学意义;与治疗前相比,8周末低剂量组总胆固醇明显增高(P<0.05);高剂量组BMI、血糖、总胆固醇和甘油三酯明显增高(P<0.05或P<0.01)。结论:奥氮平治疗精神分裂症的剂量范围内,低剂量和高剂量起效时间及疗效相当,但均可影响脂代谢;高剂量对血糖、血脂代谢的影响更明显。 Objective:To explore the curative effect and influence on glucose and lipid metabolism of olanzapine with different doses in patients with schizophrenia.Method:Ninety-six patients with schizophrenia were randomly divided into olanzapine low dose group(50 cases,10 mg/d)and high dose group(46 cases,10 mg/d).The assessment of positive and negative syndrome scale (PANSS) was preformed,the body mass index (BMI) was measured and the blood glucose and blood lipid were detected before treatment and after 2,4,8 weekends,respectively.After 8 weeks,curative effect was evaluated.Results:The reacting time and the curative effect in the two groups were no significantly difference.Compared with before treatment,the level of total cholesterol in lower dose group was significantly increased (P0.05);BMI,the levels of blood glucose and blood lipid in high dose group were significantly increased at 8 weeks after treatment(P0.05 or P0.01).Conclusion:In the therapeutic dose range,olanzapine with low does or high does can make equal reacting time,curative effect and affecting blood lipid metabolism in patients with schizophrenia;High dose is more obvious influence on blood sugar and blood fat metabolismcan.
作者 徐勇 于建华
出处 《临床精神医学杂志》 2013年第4期248-250,共3页 Journal of Clinical Psychiatry
关键词 精神分裂症 奥氮平 疗效 血糖 血脂 schizophrenia olanzapine efficacy blood glucose blood lipid
  • 相关文献

参考文献7

  • 1杨春强,李宝珠.阿立哌唑与奥氮平对体质量、血糖影响的对照研究[J].临床精神医学杂志,2009,19(5):339-340. 被引量:7
  • 2Simpson GM, Glick ID, Weiden PJ, et al. Randomized, controlled, double-blind multicenter comparison of efficacy and tolerability of ziprasi done and olanzapine in acutely Ⅲ inpatients with schizo- phrenia and schizoaffective disorder [ J ]. Am J Psychiatry, 2004, 161 : 1837-1847.
  • 3Sacher J,Mossaheb N,Spindelegger C,et al. Effects of Olanzapine and Ziprasidone on glucose tolerance in healthy volunteers [ J ].Neuropsyehopharmaeology, 2008,33 : 1633-1641.
  • 4Dwyer DS, Lu XH, Bradley RJ, et al. Cytotoxieity of conventional and atypical antipsyehotie drugs in relation to glucose metabolism [ J ]. Brain Res ,2003,971:31-39.
  • 5刘娟.精神分裂症与2型糖尿病[J].精神医学杂志,2009,22(4):312-314. 被引量:9
  • 6Kroeae WK, Hufeisen SJ, Popadak BA, et al. H1 -histamine receptor affinity predicts short-term weight gain for typical and atypical anti- psychotic drug[ J]. Neuropsychopharmacology ,2003,28:519-526.
  • 7徐勇,于建华.抗精神病药物与精神分裂症病人糖代谢异常[J].齐鲁医学杂志,2010,25(5):469-470. 被引量:14

二级参考文献24

共引文献27

同被引文献143

引证文献16

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部